Breaking News Instant updates and real-time market news.

ABEO

Abeona Therapeutics

$2.62 /

+0.055 (+2.14%)

07:07
01/09/20
01/09
07:07
01/09/20
07:07

Abeona announces resignation of Chief Scientific Officer Tim Miller

Abeona Therapeutics disclosed last night that on January 7, Tim Miller, President and Chief Scientific Officer, notified the company he is resigning from the company on January 10.

ABEO Abeona Therapeutics
$2.62 /

+0.055 (+2.14%)

12/30/19 H.C. Wainwright
Abeona Therapeutics price target lowered to $11 from $15 at H.C. Wainwright
12/20/19 Cantor Fitzgerald
Abeona financing to lessen takeover chartter, says Cantor Fitzgerald
12/10/19 Cantor Fitzgerald
Abeona Therapeutics assumed with a Neutral at Cantor Fitzgerald
08/15/19
Fly Intel: Top five analyst downgrades

TODAY'S FREE FLY STORIES

Recommendations
Insulet should be bought on selloff from guidance, says Piper Sandler » 05:14
02/26/20
02/26
05:14
02/26/20
05:14
PODD

Insulet

$197.03 /

-10.46 (-5.04%)

Insulet last night…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Salesforce results strong across the board, says Jefferies » 05:11
02/26/20
02/26
05:11
02/26/20
05:11
CRM

Salesforce

$181.65 /

-4.26 (-2.29%)

Salesforce last night…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Evolent Health price target raised to $17 from $10.15 at Piper Sandler » 05:07
02/26/20
02/26
05:07
02/26/20
05:07
EVH

Evolent Health

$10.18 /

-1.13 (-9.99%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Regeneron downgraded to Neutral from Outperform at Baird » 05:04
02/26/20
02/26
05:04
02/26/20
05:04
REGN

Regeneron

$442.34 /

+16.05 (+3.77%)

, NVS

Novartis

$88.01 /

-2.06 (-2.29%)

Baird analyst Brian…

Baird analyst Brian Skorney downgraded Regeneron Pharmaceuticals (REGN) to Neutral from Outperform with an unchanged price target of $410. The stock closed Tuesday up 4% to $442.35. The analyst appreciates the "tailwind granted by safety concerns" related to Eylea competitor, Novartis' (NVS) Beovu, he notes the shares are up 50% since his August 2019 upgrade. While the fall of Beovu certainly near-term pressure on Eylea market share, this has now been accounted for in the share price, Skorney tells investors in a research note. Skorney adds that while Dupixent and Regeneron's pipeline "continue to look good," he prefers to take a "wait and see approach."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Intercept upgraded to Buy from Neutral at Citi » 04:58
02/26/20
02/26
04:58
02/26/20
04:58
ICPT

Intercept

$84.52 /

-6.25 (-6.89%)

Citi analyst Joel Beatty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
E-Trade downgraded to Market Perform from Outperform at Raymond James » 04:56
02/26/20
02/26
04:56
02/26/20
04:56
ETFC

E-Trade

$48.52 /

-1.88 (-3.73%)

, MS

Morgan Stanley

$48.02 /

-1.65 (-3.32%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Toll Brothers downgraded to Market Perform from Outperform at Raymond James » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
TOL

Toll Brothers

$44.28 /

-2.765 (-5.88%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
nLight management to meet with Craig-Hallum » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
LASR

nLight

$16.30 /

-0.61 (-3.61%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Cerence management to meet with Oppenheimer » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
CRNC

Cerence

$26.49 /

-0.16 (-0.60%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Flowserve management to meet with RBC Capital » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
FLS

Flowserve

$41.75 /

-1.82 (-4.18%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Week of 2/21 MBA Mortgage Applications to be released at 07:00  04:55
02/26/20
02/26
04:55
02/26/20
04:55
 
Conference/Events
Ares Capital management to meet with JPMorgan » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
ARCC

Ares Capital

$17.86 /

-0.815 (-4.36%)

Meeting to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
HyreCar management to meet with Susquehanna » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
HYRE

HyreCar

$3.63 /

-0.16 (-4.22%)

Meeting to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
MKS Instruments management to meet with KeyBanc » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
MKSI

MKS Instruments

$101.93 /

-3.16 (-3.01%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Vocera management to meet with RBC Capital » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
VCRA

Vocera

$26.64 /

+0.59 (+2.26%)

Meeting to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
IFF management to meet with UBS » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
IFF

IFF

$124.00 /

-3.92 (-3.06%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 7 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Amedisys management to meet with SunTrust » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
AMED

Amedisys

$184.73 /

-7.87 (-4.09%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Week of 2/21 EIA Petroleum Status Report to be released at 10:30  04:55
02/26/20
02/26
04:55
02/26/20
04:55
 
General news
Week of 2/21 MBA Mortgage Applications to be released at 07:00  04:55
02/26/20
02/26
04:55
02/26/20
04:55
 
Conference/Events
Jack Henry management to meet with Stephens » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
JKHY

Jack Henry

$163.71 /

-4.39 (-2.61%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
The Genome Partnership to hold a meeting » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
TWST

Twist Bioscience

$31.52 /

-1.51 (-4.57%)

AGBT General Meeting 2020…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 7 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Southern Company management to meet with Guggenheim » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
SO

Southern Company

$66.85 /

-0.94 (-1.39%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Constellation Brands management to meet with RBC Capital » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
STZ

Constellation Brands

$195.36 /

-6.11 (-3.03%)

Meeting to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
HCP management to meet with RBC Capital » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
HCP

HCP

$0.00 /

+ (+0.00%)

Group Dinner Meeting to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Tempur Sealy management to meet with Piper Sandler » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
TPX

Tempur Sealy

$81.92 /

-4.55 (-5.26%)

Meeting to be held in New…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 7 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.